المؤلفون: Chen WY; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts., Ballman KV; Department of Biostatistics, Mayo Clinic, Rochester, Minnesota., Partridge AH; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts., Hahn OM; Alliance Protocol Operations Office, University of Chicago, Chicago, Illinois., Briccetti FM; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts., Irvin WJ; Bon Secours Cancer Institute, Richmond, Virginia., Symington B; Memorial Hospital of Sweetwater County, Rock Springs, Wyoming., Visvanathan K; Sidney Kimmel Cancer Center at Johns Hopkins University, Baltimore, Maryland., Pohlmann PR; Department of Breast Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston., Openshaw TH; Cape Cod Hospital, Hyannis, Massachusetts., Weiss A; Department of Surgery, University of Rochester, Rochester, New York., Winer EP; Yale Cancer Center, New Haven, Connecticut., Carey LA; UNC Lineberger Cancer Center, University of North Carolina, Chapel Hill., Holmes MD; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

المصدر: JAMA [JAMA] 2024 May 28; Vol. 331 (20), pp. 1714-1721.

نوع المنشور: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Inflammatory Agents, Non-Steroidal*/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal*/adverse effects , Anti-Inflammatory Agents, Non-Steroidal*/therapeutic use , Aspirin*/administration & dosage , Aspirin*/adverse effects , Aspirin*/therapeutic use , Breast Neoplasms*/drug therapy , Breast Neoplasms*/metabolism , Breast Neoplasms*/mortality , Breast Neoplasms*/pathology, Adult ; Aged ; Female ; Humans ; Middle Aged ; Cancer Survivors/statistics & numerical data ; Chemotherapy, Adjuvant ; Disease-Free Survival ; Double-Blind Method ; Neoplasm Recurrence, Local/epidemiology ; Neoplasm Recurrence, Local/prevention & control ; Follow-Up Studies ; Young Adult ; American Indian or Alaska Native/statistics & numerical data ; Asian/statistics & numerical data ; Black or African American/statistics & numerical data ; Hispanic or Latino/statistics & numerical data ; Native Hawaiian or Other Pacific Islander/statistics & numerical data ; White/statistics & numerical data ; United States/epidemiology ; Canada/epidemiology ; Administration, Oral